retatrutide trial news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v A new clinical trial from

Medical Oversight How Each Program Monitors Your Progress Amazon One Medical: GLP-1 management integrated into ongoing primary care relationship Regular follow-up appointments with the same provider over time Integrated lab work and cardiovascular monitoring Clinician visibility into full health picture not just weight loss metrics Dose adjustments handled through scheduled consultations with continuity provider Strongest medical oversight model currently available in the GLP-1 telehealth market Direct Meds: Licensed provider review at intake and prescription issuance Nurse support included throughout treatment period Telehealth-based ongoing access for clinical questions Less integrated with broader primary care than Amazon's model Appropriate for patients whose primary care relationship exists separately The bottom line on oversight: Amazon One Medical offers a meaningfully more integrated and clinically comprehensive oversight model

Trybe Labs will allow Hims & Hers to perform at-home blood draws and more comprehensive pretreatment testing

CrossRef Feasibility of terahertz reflectometry for discrimination of human early gastric cancers Young Bin Ji, Chan Hyuk Park, Hyunki Kim, Sang-Hoon Kim, Gyu Min Lee, Sam Kyu Noh, Tae-In Jeon, Joo-Hiuk Son, Yong-Min Huh, Seungjoo Haam, Seung Jae Oh, Sang Kil Lee, Jin-Suck Suh Biomedical Optics Express.2015

Aliquam feugiat dapibus nunc, sit amet aliquam metus sollicitudin eget

After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead